BioMarin Pharmaceutical, Inc. (BMRN)
60.16
-0.98
(-1.60%)
USD |
NASDAQ |
Dec 24, 16:00
BioMarin Pharmaceutical Cash and Short Term Investments (Annual): 1.138B for Dec. 31, 2024
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 249.95M |
| Gilead Sciences, Inc. | 11.57B |
| Merck & Co., Inc. | 13.76B |
| AbbVie, Inc. | 5.555B |
| Bristol Myers Squibb Co. | 10.86B |